MedPath

Exploring and evaluating the hand and wrist associated modules and solution intended for the ReHyb system. Study 2A: Usability and feasibility of the combination of serious gaming and functional electrical stimulatio

Not Applicable
Conditions
paresis in wrist or fingers due to ischemic or hemorrhagic stroke
I61
I63
I64
Intracerebral haemorrhage
Cerebral infarction
Stroke, not specified as haemorrhage or infarction
Registration Number
DRKS00025761
Lead Sponsor
Schön Klinik Bad Aibling
Brief Summary

The combination of SG with ccFES is feasible and well-accepted among patients after stroke. It seems that the additional use of ccFES may be more beneficial for severely impaired patients as it enables the execution of the serious game. These findings provide valuable implications for the development of rehabilitation systems by combining different therapeutic interventions to increase patients’ benefit and proposes system modifications for home use.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
21
Inclusion Criteria

ischemic or hemorrhagic stroke
- age>=18
- cognitively able to follow instructions
- low level or no pain in wrist or fingers (NRS<4)
- functional impairment in wrist or fingers (MRC<=4)
- level of spasticity in the affected limb (MAS<=3)
- able to sit in a chair for the duration of the session (about 1 hour)

Exclusion Criteria

pregnancy, severe psychiatric disorders, active implantable devices, metal implants within the stimulated area, severe epilepsy or frequent seizures in the past, cancer, wounds in the application area of the electrodes, no sensitivity in the fingers or wrist, no motion resulting from FES

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
usability and feasibility of the combination of FES and serious gaming, evaluated using a questionnaire that includes the IMI (intrinsic motivation inventory), NASA-TLX (Nasa Task Load Index) and the SUS (System Usability Scale)
Secondary Outcome Measures
NameTimeMethod
training duration, technical and user documentation
© Copyright 2025. All Rights Reserved by MedPath